Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BI-2493
i
Other names:
BI-2493
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Boehringer Ingelheim
Drug class:
pan-KRAS inhibitor
Related drugs:
‹
BI 1701963 (1)
YL-17231 (1)
BI 1701963 (1)
YL-17231 (1)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12C
Solid Tumor
KRAS G12C
Solid Tumor
BI-2493
Sensitive: D – Preclinical
BI-2493
Sensitive
:
D
BI-2493
Sensitive: D – Preclinical
BI-2493
Sensitive
:
D
KRAS G12D
Solid Tumor
KRAS G12D
Solid Tumor
BI-2493
Sensitive: D – Preclinical
BI-2493
Sensitive
:
D
BI-2493
Sensitive: D – Preclinical
BI-2493
Sensitive
:
D
KRAS A146V
Solid Tumor
KRAS A146V
Solid Tumor
BI-2493
Sensitive: D – Preclinical
BI-2493
Sensitive
:
D
BI-2493
Sensitive: D – Preclinical
BI-2493
Sensitive
:
D
KRAS G12V
Solid Tumor
KRAS G12V
Solid Tumor
BI-2493
Sensitive: D – Preclinical
BI-2493
Sensitive
:
D
BI-2493
Sensitive: D – Preclinical
BI-2493
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.